Race Oncology has submitted a human ethics regulatory package for its phase I trial in solid tumour patients using the ...

The gelded son of Unified ran seventh in the G1 Champagne after an impressive debut, so gets class relief here ...

Results from the head-to-head study showed treatment with Zepbound resulted in 47% greater relative weight loss than Wegovy, ...

Researchers from Suzhou Siran Biotech Co. Ltd. presented the discovery and preclinical characterization of SA-1211, an N-acetylgalactosamine (GalNAc)-conjugated siRNA dimer targeting both hepatitis B ...

B.C. is the only area in North America that Himsworth is aware of that includes environmental testing as part of a regular ...

At the Breakthroughs in Muscular Dystrophy special meeting held in Chicago Nov. 19-20, 2024, and organized by the American Society of Gene & Cell Therapy (ASGCT), multiple interventions at the RNA ...

Korro Bio, Inc. (NASDAQ:KRRO) is making waves in the biotechnology sector with its innovative RNA editing platform, positioning itself as a potential leader in the treatment of Alpha-1 Antitrypsin ...

Korro Bio, Inc. (NASDAQ:KRRO) is making waves in the biotechnology sector with its innovative RNA editing platform, positioning itself as a potential leader in the treatment of Alpha-1 Antitrypsin ...